ArticleVirology journal2026
The prognostic value of red cell distribution width-to-albumin ratio (RAR) in COVID-19 pneumonia: implications for early diagnosis.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the diagnostic value of red blood cell distribution width-to-albumin ratio (RAR), a biomarker integrating hematological and metabolic information, for COVID-19 pneumonia.
methodsThis retrospective study analyzed clinical data from 2,205 patients with COVID-19. RAR values were calculated as the ratio of red blood cell distribution width (RDW) to serum albumin concentration. Diagnostic performance of RAR in COVID-19 pneumonia was assessed using receiver operating characteristic (ROC) curve analysis, and the optimal cut-off was determined. Mediation analysis was conducted to examine the role of chronological age in the association between RAR and COVID-19 pneumonia risk.
resultsAmong COVID-19 patients, RAR demonstrated strong diagnostic performance for COVID-19 pneumonia, with area under the curve (AUC) of 0.769 [95% confidence interval (CI): 0.747-0.791], sensitivity of 76.8%, and specificity of 65.3% at the optimal cut-off value of 0.154. Its diagnostic utility likely stems from simultaneously reflecting hematopoietic dysfunction (elevated RDW) and systemic metabolic imbalance (hypoalbuminemia). Mediation analysis indicated that chronological age accounted for 14.16% of the association between elevated RAR and COVID-19 pneumonia risk (β = 0.1139, 95%CI: 0.0802-0.1524).
conclusionRAR represents a promising biomarker for the early detection and risk stratification of COVID-19 pneumonia. By simultaneously capturing hematologic and metabolic disturbances, RAR provides a more comprehensive reflection of disease severity. The observed age-mediation effect suggests that elderly individuals with elevated RAR may face heightened risk, warranting enhanced clinical monitoring or prioritized intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.